A 55-year-old who loses 40 pounds and normalizes their blood pressure, blood sugar, and cholesterol has potentially added years to their life
In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
Myth: GLP-1 patches can completely replace diet and exercise
545 In the development of drugs for UC, in addition to continuing to optimize existing drug targets and therapeutic strategies, we should also focus on the development of drugs with novel mechanisms of action
Tran partners closely with you to assess eligibility, explain benefits and potential side-effects (like nausea or gastrointestinal discomfort), and monitor your progress over time